date,title,source
Oct-31-18,Motif Bio to participate at upcoming Jefferies London Healthcare Conference,GlobeNewswire
Jan-17-19,Antimicrobials Working Group Announces Updates to Leadership Team,PR Newswire
Feb-14-19,Motif Bio Receives Complete Response Letter from the FDA,GlobeNewswire
Feb-19-19,Motif Bio Conference Call and Webcast,GlobeNewswire
Feb-20-19,MTFB: FDA Issues CRL for Iclaprim,Zacks Small Cap Research
Mar-20-19,"The Daily Biotech Pulse: FDA Nod For Sage's Postpartum Depression Drug, Pfizer Invests In Gene Therapy Company",Benzinga
Mar-20-19,Motif Bio Granted Meeting with U.S. FDA regarding Iclaprim,GlobeNewswire
Apr-04-19,Motif Bio to Present Iclaprim Data at ECCMID 2019,GlobeNewswire
Apr-12-19,Antimicrobials Working Group Highlights Member Company Participation at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID),PR Newswire
Apr-15-19,Motif Bio Reports Fiscal Year 2018 Results,GlobeNewswire
Apr-16-19,"The Daily Biotech Pulse: J&J Earnings, FDA Nod For Medicinova, Proteon To Explore Strategic Alternatives",Benzinga
Apr-16-19,Motif Bio Presents New Iclaprim Data at ECCMID 2019,GlobeNewswire
Apr-26-19,Motif Bio plc: Notice of Annual General Meeting,GlobeNewswire
Apr-26-19,Motif Bio Announces Appointment of Andrew Powell to Board of Directors,GlobeNewswire
May-01-19,Motif Bio Signs Agreement with Lamellar Biomedical,GlobeNewswire
May-03-19,Motif Bio meeting with U.S. FDA held as planned,GlobeNewswire
